Wegovy® Lawsuit

What is Wegovy?

Wegovy is part of the drug class semaglutide. It is an injectable medication that the FDA-approved for weight loss. 诺和诺德开发了治疗糖尿病和肥胖的西马鲁肽药物. 它们的工作原理是调节胰岛素的释放，模仿天然激素，让人在吃完饭后产生饱腹感. These are called satiety hormones. Glucagon-like peptide 1 (GLP-1) is a satiety hormone. 

Wegovy是一种GLP-1受体激动剂(GLP-1 RA)，这意味着它模仿天然GLP-1激素. Other GLP-1 RA medications include semaglutide drugs like Ozempic® and Rybelsus®. Wegovy是在糖尿病药物测试发现西马鲁肽药物导致体重减轻后开发的. Wegovy is a higher dosage version of the diabetes drug Ozempic. 

The drug’s FDA approved label 用于慢性体重管理超重或肥胖的成年人至少有一个体重相关的条件. 与体重有关的疾病包括高血压、2型糖尿病和高胆固醇. 该批准还表明，Wegovy应该与生活方式的改变一起使用，如减少热量摄入和增加锻炼.

Wegovy differs from other semaglutide drugs in its dosage and approved treatable conditions. 

Concerns over Wegovy: off-label use background

对Ozempic的许多公开担忧源于该药物在标签外的流行减肥用途. 然而，Wegovy被批准为某些成年人和12岁以上儿童的减肥药. 

当药物用于治疗未经fda批准的疾病时，就会发生标签外使用. In general, 当医生开处方或建议超说明书使用时，这是一种安全且可接受的做法. 

In Wegovy’s case, 当医学上没有超重或肥胖的人使用它来控制体重时，可能会发生标签外使用. Since the drug has not been tested when used this way, the potential for unwanted side effects may be higher.

Health issues related to Wegovy

Wegovy的处方标签强调了该药物的几种潜在副作用和反应. 这些反应是在临床试验中观察到的，并包括在药物的警告标签上:

• Abdominal distension
• Abdominal pain
• Acute gallbladder disease
• Acute kidney injury
• Acute pancreatitis
• Allergic reactions
• Constipation
• Diarrhea
• Dizziness
• Dyspepsia (indigestion)
• Eructation (burping)    
• Fatigue
• Flatulence
• Gastroenteritis
• Gastroesophageal reflux disease
• Headache
• Hypoglycemia (in diabetic patients)
• Nasopharyngitis (cold)
• Nausea
• Thyroid C-cell tumors
• Vomiting

Studies, 消费者报告和诉讼强调了西马鲁肽药物的其他副作用.

一项研究将GLP-1 RAs与小肠的不良影响和肠道和胃阻塞联系起来. Wegovy使用者也报告因胃轻瘫(胃麻痹)而住院。, 哪些没有被包括在药物的警告标签上，但被认为是导致一些使用者出现这种情况的原因.

These adverse events can be serious or even life-threatening. 服用Wegovy的患者应确保与医生讨论所有这些潜在的副作用. 

What are the Wegovy lawsuits about?

人们在经历了他们认为是由药物引起的严重和意想不到的副作用后，向Wegovy提起诉讼. For example, in September 2023, 一名由莫特利·赖斯(Motley Rice)代理的宾夕法尼亚州妇女对该药物的制造商提起了诉讼, Novo Nordisk.

The lawsuit details our client’s severe gastrointestinal issues and subsequent hospitalization for gastroparesis after taking Wegovy. 这起诉讼主要针对Wegovy及其制造商诺和诺德的两项索赔.

• Failure to warn: 宾夕法尼亚州的诉讼声称，原告经历了药物警告标签上没有包括的副作用.
• Negligent misrepresentation and marketing: 该诉讼还称，诺和诺德歪曲了潜在副作用的严重程度，并针对青少年和少数族裔进行了有害的营销活动. 

Besides lawsuits filed by people harmed by the drug在美国，Wegovy还卷入了制药商诺和诺德(Novo Nordisk)提起的诉讼. 这家制药商已经对健康和医疗水疗中心提起了诉讼, 减肥诊所和复方药房出售非品牌版本的Wegovy和Ozempic.

Consumers should be aware of these off-brand versions, which are untested and may come with additional side effects.

如果你或你所爱的人服用了维格威，并经历了严重的副作用，比如胃轻瘫, you may be eligible to file a lawsuit.

我们的律师事务所曾代表原告在人身伤害诉讼中获得赔偿. 通过判决或和解的补偿可以帮助你支付医疗费用，并在你康复期间让你安心.

Is there a Wegovy class action lawsuit?

As of October 2023, 没有针对诺和诺德的集体药物诉讼. 

一个或多个原告为更大的群体或“集体”提起集体诉讼.” They can result in large verdicts or settlement awards. 然后，被纳入这一群体的人可以申请获得他们应得的经济赔偿.

Our medical drug litigation experience

我们的医疗律师已经代理了数千名因危险的处方药和非处方药而严重受伤的患者. We understand that as a patient or family member, what you know about your or a loved one’s medications may be limited. 

If you believe a medicine made you sick or hurt you, our attorneys have the resources needed to thoroughly investigate and:

• Identify potentially harmful medicines
• Review if the medicine hurt you
• Review the medicine manufacturer’s compliance with FDA regulations
• 检查制造商对潜在副作用的警告是否充分
• Recognize other issues that could affect your potential claim

Learn more about our medical drug experience here.

没有咨询医生就停止服用处方药. 在没有医生建议的十大赌搏靠谱平台下载停止服用处方药可能会导致受伤或死亡.